These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38605270)

  • 1. Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort.
    Mottaghi M; Gu L; Deivasigamani S; Adams ES; Parrish J; Amling CL; Aronson WJ; Kane CJ; Terris MK; Guerrios-Rivera L; Cooperberg MR; Klaassen Z; Freedland SJ; Polascik TJ
    Prostate Cancer Prostatic Dis; 2024 Apr; ():. PubMed ID: 38605270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of Models to Predict Pathological Outcomes of Radical Prostatectomy in Regional and National Cohorts.
    Ötleş E; Denton BT; Qu B; Murali A; Merdan S; Auffenberg GB; Hiller SC; Lane BR; George AK; Singh K
    J Urol; 2022 Feb; 207(2):358-366. PubMed ID: 34551595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
    Gandaglia G; Barletta F; Robesti D; Scuderi S; Rajwa P; Gomez Rivas J; Ibanez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler W; Marra G; Stabile A; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Sierra JM; Porpiglia F; Picchio M; van den Bergh R; Shariat SF; Montorsi F; Briganti A
    Eur Urol Oncol; 2023 Dec; 6(6):543-552. PubMed ID: 37270378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
    Oderda M; Diamand R; Albisinni S; Calleris G; Carbone A; Falcone M; Fiard G; Gandaglia G; Marquis A; Marra G; Parola C; Pastore A; Peltier A; Ploussard G; Roumeguère T; Sanchez-Salas R; Simone G; Smelzo S; Witt JH; Gontero P
    BJU Int; 2021 Mar; 127(3):318-325. PubMed ID: 32869940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transperineal template saturation and conventional biopsy for stage prediction in prostate cancer.
    Lehner F; Crippa A; Sigg S; Eberli D; Mortezavi A
    BJU Int; 2023 Dec; 132(6):696-704. PubMed ID: 37704215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
    Gandaglia G; Martini A; Ploussard G; Fossati N; Stabile A; De Visschere P; Borgmann H; Heidegger I; Steinkohl F; Kretschmer A; Marra G; Mathieu R; Surcel C; Tilki D; Tsaur I; Valerio M; Van den Bergh R; Ost P; Gontero P; Montorsi F; Briganti A;
    Eur Urol; 2020 Aug; 78(2):138-142. PubMed ID: 32268944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
    Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between Briganti, Partin and MSKCC tools in predicting positive lymph nodes in prostate cancer: a systematic review and meta-analysis.
    Cimino S; Reale G; Castelli T; Favilla V; Giardina R; Russo GI; Privitera S; Morgia G
    Scand J Urol; 2017 Oct; 51(5):345-350. PubMed ID: 28644701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients.
    Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Sorce G; Hoeh B; Hohenhorst L; Tian Z; Saad F; Tilki D; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
    Clin Genitourin Cancer; 2022 Oct; 20(5):e380-e389. PubMed ID: 35618597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.
    Bandini M; Marchioni M; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Shariat SF; Montorsi F; Saad F; Briganti A; Tilki D; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):449-456. PubMed ID: 29249688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients.
    Hueting TA; Cornel EB; Somford DM; Jansen H; van Basten JA; Pleijhuis RG; Korthorst RA; van der Palen JAM; Koffijberg H
    Eur Urol Oncol; 2018 Oct; 1(5):411-417. PubMed ID: 31158080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Diamand R; Ploussard G; Roumiguié M; Oderda M; Benamran D; Fiard G; Quackels T; Assenmacher G; Simone G; Van Damme J; Malavaud B; Iselin C; Descotes JL; Roche JB; Peltier A; Roumeguère T; Albisinni S
    Eur Urol; 2021 Feb; 79(2):180-185. PubMed ID: 33023770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging.
    Soeterik TFW; Hueting TA; Israel B; van Melick HHE; Dijksman LM; Stomps S; Biesma DH; Koffijberg H; Sedelaar M; Witjes JA; van Basten JA
    BJU Int; 2021 Aug; 128(2):236-243. PubMed ID: 33630398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era.
    Frego N; Paciotti M; Buffi NM; Maffei D; Contieri R; Avolio PP; Fasulo V; Uleri A; Lazzeri M; Hurle R; Saita A; Guazzoni GF; Casale P; Lughezzani G
    Front Surg; 2022; 9():829515. PubMed ID: 35284478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms.
    Lodeta B; Baric H; Hatz D; Jozipovic D; Augustin H
    BMC Urol; 2023 Nov; 23(1):190. PubMed ID: 37980520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Clinical Experience and Review of the Literature.
    Di Pierro GB; Salciccia S; Frisenda M; Tufano A; Sciarra A; Scarrone E; Del Giudice F; Asero V; Bevilacqua G; Moriconi M; Carbone A; Pastore A; Signore S; Bove P; Forte F; Emiliozzi P; Tubaro A; De Nunzio C; Canale V
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stage.
    Augustin H; Sun M; Isbarn H; Pummer K; Karakiewicz P
    Urol Oncol; 2012; 30(4):396-401. PubMed ID: 20884254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold.
    Venclovas Z; Muilwijk T; Matjosaitis AJ; Jievaltas M; Joniau S; Milonas D
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.